US$ 28.55
discontinue sulfonylurea when starting glp-1 receptor agonist Agonists: An Alternative for Rapid-Acting Insulin? Combining glucagon-like peptide-1 receptor agonists
Description
On average, patients can lose 10 to 20 percent of their body weight while taking these medications

[DOI] [PMC free article] [PubMed] [Google Scholar] 37.Buse J.B., Rosenstock J., Sesti G., Schmidt W.E., Montanya E., Brett J.H

[35] conducted the first population-based study linked the UK CPRD with the Hospital Episodes Statistics database, examining the relationship between incretin-based medications and the incidence of hospitalization due to bile duct and gallbladder diseases

10.7326/m17-2786
Direct evidence for exercise-induced weight loss without caloric restriction is heterogeneous and variable

Journal of Histochemistry and Cytochemistry, 61 , 649658
